Platelet-derived growth factor: A new clinical target on the horizon
- 1 April 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 59 (4) , 1592-1593
- https://doi.org/10.1046/j.1523-1755.2001.0590041592.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritisKidney International, 2001
- Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine KinaseScience, 2000
- PDGF receptor kinase blocker AG1295 attenuates interstitial fibrosis in rat kidney after unilateral obstructionCell and tissue research, 2000
- Effect of the Platelet-Derived Growth Factor Antagonist Trapidil on Mesangial Cell Proliferation in RatsNephron, 1999
- Novel Approach to Specific Growth Factor Inhibition in VivoThe American Journal of Pathology, 1999
- Beneficial Effects of a Novel Inhibitor of Platelet-Derived Growth Factor Receptor Autophosphorylation in the Rat with Mesangial Proliferative GlomerulonephritisGeneral Pharmacology: The Vascular System, 1998
- Trapidil inhibits human mesangiai cell proliferation: Effect on PDGF β-receptor binding and expressionKidney International, 1994
- Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor.The Journal of Experimental Medicine, 1992